Intercept Pharmaceuticals Inc
ICPT
Get informed when a big investor buys or sells
+ FollowMarket Cap$794.69M
Close$
$21.67
14% upside
Current Fair Value
14% upsideUndervalued by 14% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $794.69 Million |
|---|---|
| Enterprise Value | $915.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.41 |
| Beta | 0.88 |
| Outstanding Shares | 41,792,000 |
Return
| Return on Equity | -82.19% |
|---|---|
| Return on Assets | -15.02% |
| Return on Invested Capital | -22.54% |
Valuation & Multiples
| P/E Ratio | 5.58 |
|---|---|
| PEG | -5.52 |
| Price to Sales | 3.17 |
| Price to Book Ratio | 19.0 |
| Enterprise Value to Revenue | 3.18 |
| Enterprise Value to EBIT | -13.44 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 3.12 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data